15th Annual Winter Cancer Symposium (WCS)

15th Annual Winter Cancer Symposium (WCS)

Event Ended

This event has ended. Registration is no longer available.

Event Schedule

February 27th, 2026 1:00 PM (EST)
Central: February 27th, 2026 12:00 PM
Mountain: February 27th, 2026 11:00 AM
Pacific: February 27th, 2026 10:00 AM
March 1st, 2026 11:45 AM (EST)
Central: March 1st, 2026 10:45 AM
Mountain: March 1st, 2026 9:45 AM
Pacific: March 1st, 2026 8:45 AM

Event Overview

The field of oncology is experiencing rapid and ongoing transformations driven by groundbreaking advances in genomics, proteomics, oncogenic pathways, and therapeutic innovations. These paradigm shifts are reshaping cancer diagnosis, treatment, and survivorship care. Staying abreast of the latest evidence-based practices is essential for optimizing patient outcomes and fostering collaborative cancer care.

This interprofessional continuing education activity brings together physicians, advanced practice registered nurses, oncology nurses, physician associates/assistants, pharmacists, and healthcare professionals across disciplines.

The conference is intentionally designed to enhance communication, collaboration, and synergy across the cancer care team, while strengthening team-based approaches to patient care. Through didactic presentations, case-based panels, and interactive panel discussions, attendees will gain critical insights into the latest scientific, clinical, and supportive care advancements.

The program also addresses cross-cutting issues such as survivorship, burnout among healthcare professionals, integrative medicine, and the ethical integration of artificial intelligence in oncology practice.

Conference topics include: Survivorship, Women’s Health, and Wellness in Oncology: fertility preservation, menopause and sexual health, psychosocial care, burnout prevention, and integrative approaches to anxiety and depression. Value-Based Oncology and Innovation: implementing value-based care models, using informatics and AI to enhance outcomes, and updates in head and neck cancers and melanoma. Genitourinary and Gynecologic Malignancies: personalized therapies in prostate, bladder, kidney, cervical, uterine, and ovarian cancers, including rare histologies. Gastrointestinal and Sarcoma Oncology: new treatments for esophageal, gastric, colorectal, pancreas, liver, biliary, and GIST tumors. Lung Cancer: integrating novel immunotherapy and precision medicine strategies in small cell and non-small cell lung cancers. Breast Cancer: individualizing treatment in early-stage and metastatic settings, with focus on hormone receptor-positive, HER2-positive, and triple-negative subtypes. Hematologic Malignancies: real-world case discussions on myeloma, leukemias, lymphomas, and bone marrow transplantation.

Instructions for Credit

Thank you for attending this conference.  Your feedback is valuable to us.

To receive your Certificate of Attendance, complete and submit the Evaluation Form. Once this form is submitted your certificate will be available for download.

Registered attendees can earn a maximum of 13.50 CME/ABIM MOC/CE credits. You will be able to select the amount of credits being claimed.

Physicians: If you would like to earn MOC credit please complete the Post-Test prior to submitting the evaluation. Once submitted, you will not be able to go back to complete the Post-Test. In order for MEC to report your MOC credit, your ABIM Diplomate ID number and date of birth (mm/dd/yyyy) MUST be included in your MyMedflix user profile. A completed evaluation and passing score of 70% on the post-test is required. You will have (3) attempts to pass the test.

Pharmacists: NABP e-profile number and date of birth (mm/dd/yyyy). Your CE credits will be electronically submitted to CPE Monitor® within 60 days upon successful completion of the activity.

For questions regarding credit for this activity, please contact MEC at info@meccinc.com. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

Credits

  • AMA PRA Category 1 Credit™13.50
  • AAPA Category 113.50
  • IPCE Credits13.50
  • Nursing13.50
  • Pharmacy13.50

Universal Activity Number(s)

Pharmacist: JA4008179-0000-26-006-L01-P

Event Details

Duration
13.50 hours
Start Date
February 27th, 2026 1:00 PM (EST)
Central: February 27th, 2026 12:00 PM
Mountain: February 27th, 2026 11:00 AM
Pacific: February 27th, 2026 10:00 AM
End Date
March 1st, 2026 11:45 AM (EST)
Central: March 1st, 2026 10:45 AM
Mountain: March 1st, 2026 9:45 AM
Pacific: March 1st, 2026 8:45 AM

Target Audience

Physician
Nurses
Pharmacists
Physician Associates

Faculty & Disclosure

Faculty

No Faculty or Disclosure

Disclosure

No Faculty or Disclosure

Accreditation

In support of improving patient care, The Medical Educator Consortium is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 13.50 Interprofessional Continuing Education (IPCE) credit for learning and change.

Physician
The Medical Educator Consortium designates this live activity for a maximum of 13.50 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

“Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 13.50 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit."

Learner participation will be shared through the ACCME’s Program and Activity Reporting System (PARS).

Nursing
The Medical Educator Consortium designates this activity for 13.50 ANCC contact hours.

ILNA Coding: The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points as follows:

  • Care Continuum (OCN, CBCN, CPHON, A0CNP, ROCN): 8.0 points*

  • Care of the Pediatric Hematology and Oncology Patient (CPHON): 6.0 points*

  • Diagnosis and Staging (CBCN): 2.5 points*

  • Disease Related Biology (CPHON): 2.5 points*

  • HSCT and Cellular Therapy Process and Administration (TCTCN): 1.25 points*

  • Multi-modality Therapies (RCON): 1.25 points*

  • Nursing Practice (CBCN): 5.75 points*

  • Oncology Nursing Practice (OCN): 9.5 points*

  • Pediatric Hematology Oncology Nursing Practice (CPHON): 4.75 points*

  • Professional Practice/Performance (TCTCN, AOCNP, ROCN): 3.25 points*

  • Psychosocial Dimensions of Care (AOCNP, CPHON, OCN, CBCN): 1.75 points*

  • Quality of Life (TCTCN): 1.75 points*

  • Symptom Management, Palliative Care, Supportive Care (OCN, CPHON, AOCNP): 4.0 points*

  • Treatment (OCN, CBCN, AOCNP, CPHON, ROCN): 5.0 points*

    Total Points: 13.5

*Note that the course content applies to multiple subject areas across multiple credentials. The numerical value indicated is the maximum amount of points that can be claimed in each domain. The total amount of ILNA points claimed may not exceed the total amount of Nursing Continuing Professional Development (NCPD) awarded from this course and may only apply to the credential each nurse is renewing.

Disclaimer: ONCC review is only for designating content to be used for ILNA points and is not for NCPD accreditation. NCPD programs must be formally approved for contact hours by an acceptable accreditor/approver of nursing NCPD to be used for recertification by ONCC. If the NCPD provider fails to obtain formal approval to award contact hours by an acceptable accrediting/approval body, no information related to ONCC recertification or ILNA categories may be used in relation to the program.

Pharmacist
This Application-based activity has been approved for 13.50 contact hours (1.350 CEU) by The Medical Educator Consortium. The Universal Activity Number for this program is JA4008179-0000-26-006-L01-P. Your CE credits will be electronically submitted to CPE Monitor® within 60 days upon successful completion of the activity.

Physician Associate
The Medical Educator Consortium has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 13.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

MOC Statements